Support

Your support of the USC Mark and Mary Stevens Center for Orthobiologics will accelerate the discovery and delivery of breakthrough therapies that restore mobility, reduce pain, and transform lives. By investing in this pioneering work, you are fueling the future of regenerative medicine, helping to bring innovative treatments from the lab to the bedside faster, and giving hope to millions of patients suffering from arthritis, bone injuries, and degenerative joint disease. Together, we can reimagine what healing looks like.

Ways to Give

• Endowments
• Research support
• Education & training support

For opportunities to support the Center, please contact: 

Daisy Lau
Senior Director of Development
Health Sciences Advancement
University of Southern California
Mobile: (213) 588-6239
[email protected]

Donor Recognition

Mark and Mary Stevens’ $10 million gift launches the USC Mark and Mary Stevens Center for Orthobiologics

Orthopaedic surgeons work near-miracles in the operating room to fix broken bones and torn tendons. Yet, repairing torn cartilage, healing bone trauma, and regenerating muscle remain some of the greatest challenges in modern medicine.

Thanks to a visionary $10 million gift from USC Trustee Mark Stevens and his wife, Mary, the Keck School of Medicine of USC has established the USC Mark and Mary Stevens Center for Orthobiologics in the Department of Orthopaedic Surgery.

The center is pioneering therapies that use stem cells, platelet-rich plasma (PRP), and other biologics to accelerate healing. These treatments hold promise for patients with arthritis, cartilage injuries, tendon damage, and bone trauma.

“Millions of people suffer from arthritis and degenerative joint disease,” said Mark Stevens. “Mary and I are enthusiastic about supporting the next generation of cell-based therapies and biologics through the center.”

“Millions of people suffer from arthritis and degenerative joint disease. Mary and I are enthusiastic about supporting the next generation of cell-based therapies and biologics through the center.”

— Mark Stevens

The Stevens’ gift builds on their legacy of supporting transformational medicine at USC, including the USC Mark and Mary Stevens Neuroimaging and Informatics Institute and the USC Stevens Center for Innovation.

“This is truly a gift for the interest of patients and humanity,” said Dr. Jay R. Lieberman, Chair of Orthopaedic Surgery. “We’re focusing on translational medicine—taking discoveries from the lab and we want to move them to the clinic to improve lives.”

The new center will create a biorepository of patient tissue samples to study biological factors influencing cartilage repair, bone regeneration, and muscle healing. Researchers will also conduct pilot studies and clinical trials to evaluate the effectiveness of new therapies.

“We need to develop biologic therapies that work on a consistent basis,” added Lieberman. “But we want to enhance our understanding of biological factors that influence healing and move forward with therapies that can change lives.”

By accelerating the development of new biologics, the USC Mark and Mary Stevens Center for Orthobiologics is poised to transform treatment for patients suffering from some of the most challenging musculoskeletal conditions.